/OMMH

OMMH Stock - Omnimmune Holdings, Inc.

Q: What is the analyst price target for OMMH?

Analyst price target information is not currently available for OMMH.

Q: What is OMMH's market cap?

Market capitalization information is not currently available for OMMH.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OMMH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2006

FY2007

FY2008

FY2009

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.12

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2009	FY2008	FY2007	FY2006
Revenue	N/A	N/A	$445	N/A
Gross Profit	N/A	N/A	$445	N/A
Gross Margin	N/A	N/A	100.0%	N/A
Operating Income	$-1,522,060	$-5,475,869	$-47,609	$-8,506
Net Income	$-1,761,268	$-5,989,872	$-47,609	$-8,506
Net Margin	N/A	N/A	-10698.7%	N/A
EPS	$-0.20	$-1.00	$-0.01	$-0.00

Company Overview

Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.

Frequently Asked Questions about OMMH

What is OMMH's current stock price?

Omnimmune Holdings, Inc. (OMMH) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for OMMH?

No analyst price targets are currently available for this stock.

What sector is Omnimmune Holdings, Inc. in?

Omnimmune Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is OMMH's market cap?

Omnimmune Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does OMMH pay dividends?

No, Omnimmune Holdings, Inc. does not currently pay a dividend to shareholders.